Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features

S. A. Wang, K. Jabbar, G. Lu, S. S. Chen, N. Galili, F. Vega, D. Jones, A. Raza, H. Kantarjian, G. Garcia-Manero, T. J. McDonnell, L. J. Medeiros

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features'. Together they form a unique fingerprint.

Medicine & Life Sciences